Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Barbara Kuter"'
Autor:
Anna Giuliano, Barbara Kuter, Shari Pilon‐Thomas, Junmin Whiting, Qianxing Mo, Brett Leav, Bradley Sirak, Christopher Cubitt, Christopher Dukes, Kimberly Isaacs‐Soriano, Kayoko Kennedy, Somedeb Ball, Ning Dong, Akriti Jain, Patrick Hwu, Jeffrey Lancet
Publikováno v:
Cancer Communications, Vol 43, Iss 7, Pp 749-764 (2023)
Abstract Background Compared to the general population, cancer patients are at higher risk of morbidity and mortality following SARS‐CoV‐2 infection. The immune response to a two‐dose regimen of mRNA vaccines in cancer patients is generally low
Externí odkaz:
https://doaj.org/article/f410cd3405664639b855cb443315cee9
Autor:
Manjiri Pawaskar, Elvira Schmidt, Gary S. Marshall, Jaime Fergie, Elizabeth Richardson, Louise Parks Saldutti, Se Li, Monika Neumann, Linnea Koller, Barbara Kuter
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1, Pp 1-7 (2022)
M-M-R®II (M-M-R II) is routinely used in many countries at 12–15 months with a second dose at 4 to 6 years of age. However, the vaccine may need to be administered at other ages due to delays in the immunization schedule or in certain situations s
Externí odkaz:
https://doaj.org/article/92e3bb86aa0e48e0b44dd8ccc515fd4b
Autor:
Anne Eng Neo Goh, Eun Hwa Choi, Kulkanya Chokephaibulkit, Jaydeep Choudhury, Barbara Kuter, Ping-Ing Lee, Helen Marshall, Jin Oh Kim, Lara J. Wolfson
Publikováno v:
Expert Review of Vaccines, Vol 18, Iss 5, Pp 475-493 (2019)
Introduction: Varicella is a highly contagious infection that can lead to serious complications, particularly in high-risk groups; however, it is vaccine preventable. Disease awareness and understanding of the disease burden can strongly influence va
Externí odkaz:
https://doaj.org/article/3ddb3bf3b999472fbab90b0885b031b3
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 4, Pp 778-785 (2019)
This randomized trial conducted in France compared intramuscular (IM) and subcutaneous (SC) administration of two doses of a measles, mumps, rubella, and varicella (MMRV) combination vaccine (ProQuad®) administered one month apart to 405 children 12
Externí odkaz:
https://doaj.org/article/ad5c591274a74f75824cf4bc9b96759e
Autor:
Jacek Wysocki, Ilona Malecka, Joanna Stryczynska-Kazubska, Emmanouil Rampakakis, Barbara Kuter, Lara J. Wolfson
Publikováno v:
BMC Public Health, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background The safety and efficacy of live-attenuated varicella zoster virus (VZV) vaccines in preventing varicella and reducing associated morbidity and mortality in real-world have been previously shown. In Poland, VZV vaccination is only
Externí odkaz:
https://doaj.org/article/8bcfb52d301b4101bb9db1c8c63e568c
Autor:
Evan J, Anderson, C Buddy, Creech, Vladimir, Berthaud, Arin, Piramzadian, Kimball A, Johnson, Marcus, Zervos, Fredric, Garner, Carl, Griffin, Khozema, Palanpurwala, Mark, Turner, Jeffrey, Gerber, Richard L, Bennett, Kashif, Ali, Madhavi, Ampajwala, Gary, Berman, Jennifer, Nayak, Carey, Chronis, Barbara, Rizzardi, William J, Muller, Christopher A, Smith, George, Fuchs, Daniel, Hsia, Joanne E, Tomassini, Dianne, DeLucia, Caroline, Reuter, Barbara, Kuter, Xiaoping, Zhao, Weiping, Deng, Honghong, Zhou, Daniela, Ramirez Schrempp, Kelly, Hautzinger, Bethany, Girard, Karen, Slobod, Roderick, McPhee, Rolando, Pajon, Anne, Aunins, Rituparna, Das, Jacqueline M, Miller, Sabine, Schnyder Ghamloush, Yamna, Ali
Publikováno v:
The New England journal of medicine. 387(18)
The safety, reactogenicity, immunogenicity, and efficacy of the mRNA-1273 coronavirus disease 2019 (Covid-19) vaccine in young children are unknown.Part 1 of this ongoing phase 2-3 trial was open label for dose selection; part 2 was an observer-blind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87d962af5aa5330e6d7710b72ead9c40
https://pubmed.ncbi.nlm.nih.gov/36260859
https://pubmed.ncbi.nlm.nih.gov/36260859
Autor:
Hua, Wang, X, Chen, Zhixian, Chen, W, Lu, Gabriele, Poerschke, Karen, Eves, Jacqueline, Gress, Barbara, Kuter
Publikováno v:
The Southeast Asian journal of tropical medicine and public health. 35(4)
In Jiangsu, 30% of children between the ages of 5 and 8 years test seropositive for hepatitis A. The safety, tolerability, and immunogenicity of a 2-dose regimen (0, 6 months) of VAQTA (0.5 ml of 25U) administered IM in 50 healthy children aged 5 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc0c5d16108a5d09b6d8606a629fdafc
https://pubmed.ncbi.nlm.nih.gov/15916096
https://pubmed.ncbi.nlm.nih.gov/15916096
Autor:
Alan Werzberger, Barbara Mensch, Barbara Kuter, Leora Brown, John Lewis, Robert Sitrin, William Miller, Daniel Shouval, Brian Wiens, Gary Calandra, John Ryan, Philip Provost, David Nalin
Publikováno v:
The New England journal of medicine. 327(7)
Although inactivated hepatitis A vaccine is known to be well tolerated and immunogenic in healthy children and adults, its efficacy has yet to be established.To evaluate the efficacy of the hepatitis A vaccine in protecting against clinically apparen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e653f2e3f74517cf774c61dd95f1e331
https://pubmed.ncbi.nlm.nih.gov/9547152
https://pubmed.ncbi.nlm.nih.gov/9547152
Autor:
Sharon Frey, Ron Dagan, Yaffa Ashur, Xiao Q. Chen, Jose Ibarra, Herwig Kollaritsch, Mark H. Mazur, Gregory A. Poland, Keith Reisinger, Emmanuel Walter, Pierre Van Damme, Jean H. Braconier, Ingrid Uhnoo, Martin Wahl, Mark M. Blatter, Dennis Clements, David Greenberg, Robert M. Jacobson, S. Ragnar Norrby, Mina Rowe, Daniel Shouval, Sue S. Simmons, Jan van Hattum, Solveig Wennerholm, Jacqueline O'Brien Gress, Ivan Chan, Barbara Kuter
Publikováno v:
The Journal of Infectious Diseases. 182:1005-1006
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9ac898f22dfe1c6c84c3ff831f50f29
https://doi.org/10.1086/315793
https://doi.org/10.1086/315793
Autor:
BARBARA KUTER, HOLLY MATTHEWS, HENRY SHINEFIELD, STEVE BLACK, PENELOPE DENNEHY, BARBARA WATSON, KEITH REISINGER, LEE LIAN KIM, LISA LUPINACCI, JONATHAN HARTZEL, IVAN CHAN, THE STUDY GROUP FOR VARIVAX
Publikováno v:
Pediatric Infectious Disease Journal; Feb2004, Vol. 23 Issue 2, p132-137, 6p